- Your cart is empty
- Continue Shopping
Novartis to acquire RNA-focused Avidity Biosciences for $12B
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — Novartis said Sunday ...